CN107815432A - 一种人用灭活乳酸菌制剂及其用途 - Google Patents
一种人用灭活乳酸菌制剂及其用途 Download PDFInfo
- Publication number
- CN107815432A CN107815432A CN201711285744.2A CN201711285744A CN107815432A CN 107815432 A CN107815432 A CN 107815432A CN 201711285744 A CN201711285744 A CN 201711285744A CN 107815432 A CN107815432 A CN 107815432A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- inactivation
- strain
- preparation
- people
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002779 inactivation Effects 0.000 title claims abstract description 125
- 241000186660 Lactobacillus Species 0.000 title claims abstract description 104
- 229940039696 lactobacillus Drugs 0.000 title claims abstract description 104
- 238000002360 preparation method Methods 0.000 title claims abstract description 63
- 230000001580 bacterial effect Effects 0.000 claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 24
- 230000003115 biocidal effect Effects 0.000 claims abstract description 22
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 20
- 230000036541 health Effects 0.000 claims abstract description 17
- 210000005000 reproductive tract Anatomy 0.000 claims abstract description 17
- 239000006041 probiotic Substances 0.000 claims abstract description 15
- 235000018291 probiotics Nutrition 0.000 claims abstract description 15
- 210000000214 mouth Anatomy 0.000 claims abstract description 13
- 230000000529 probiotic effect Effects 0.000 claims abstract description 13
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 11
- 210000003708 urethra Anatomy 0.000 claims abstract description 11
- 241001478240 Coccus Species 0.000 claims abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims abstract description 10
- 239000000341 volatile oil Substances 0.000 claims abstract description 9
- 206010057190 Respiratory tract infections Diseases 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 8
- 125000005456 glyceride group Chemical group 0.000 claims abstract description 7
- 241000238631 Hexapoda Species 0.000 claims abstract description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 140
- 241000894006 Bacteria Species 0.000 claims description 100
- 239000004310 lactic acid Substances 0.000 claims description 70
- 235000014655 lactic acid Nutrition 0.000 claims description 70
- 239000000829 suppository Substances 0.000 claims description 21
- 230000000694 effects Effects 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 241000218492 Lactobacillus crispatus Species 0.000 claims description 9
- 210000000481 breast Anatomy 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 241000194032 Enterococcus faecalis Species 0.000 claims description 5
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 5
- 244000057717 Streptococcus lactis Species 0.000 claims description 5
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000007938 effervescent tablet Substances 0.000 claims description 5
- 241001608472 Bifidobacterium longum Species 0.000 claims description 4
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 4
- 210000002345 respiratory system Anatomy 0.000 claims description 4
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 3
- 241000186011 Bifidobacterium catenulatum Species 0.000 claims description 3
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 241000186712 Lactobacillus animalis Species 0.000 claims description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 3
- 244000199866 Lactobacillus casei Species 0.000 claims description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 3
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 3
- 241000186870 Lactobacillus ruminis Species 0.000 claims description 3
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 3
- 241000191996 Pediococcus pentosaceus Species 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 229940121375 antifungal agent Drugs 0.000 claims description 3
- 239000003429 antifungal agent Substances 0.000 claims description 3
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 3
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 3
- 230000000415 inactivating effect Effects 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 241000194108 Bacillus licheniformis Species 0.000 claims description 2
- 244000063299 Bacillus subtilis Species 0.000 claims description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 2
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 2
- 241000186012 Bifidobacterium breve Species 0.000 claims description 2
- 241000193171 Clostridium butyricum Species 0.000 claims description 2
- 240000001929 Lactobacillus brevis Species 0.000 claims description 2
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 2
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 claims description 2
- 241000606124 Bacteroides fragilis Species 0.000 claims 1
- 241000191998 Pediococcus acidilactici Species 0.000 claims 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 46
- 210000001215 vagina Anatomy 0.000 description 31
- 241000193830 Bacillus <bacterium> Species 0.000 description 21
- 230000001225 therapeutic effect Effects 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 12
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 10
- 230000009286 beneficial effect Effects 0.000 description 10
- 210000002919 epithelial cell Anatomy 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 10
- 229960002509 miconazole Drugs 0.000 description 10
- 241001561398 Lactobacillus jensenii Species 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 239000012530 fluid Substances 0.000 description 8
- 229960000282 metronidazole Drugs 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 241000222122 Candida albicans Species 0.000 description 6
- 239000001828 Gelatine Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 5
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 5
- 206010007134 Candida infections Diseases 0.000 description 5
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 201000003984 candidiasis Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 210000000664 rectum Anatomy 0.000 description 5
- 230000007958 sleep Effects 0.000 description 5
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000001464 adherent effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229960000988 nystatin Drugs 0.000 description 3
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 2
- 241000207202 Gardnerella Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010022678 Intestinal infections Diseases 0.000 description 2
- 241001324870 Lactobacillus iners Species 0.000 description 2
- 241000186783 Lactobacillus vaginalis Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000007313 Reproductive Tract Infections Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 235000020299 breve Nutrition 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229930016911 cinnamic acid Natural products 0.000 description 2
- 235000013985 cinnamic acid Nutrition 0.000 description 2
- 239000006783 corn meal agar Substances 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229940084434 fungoid Drugs 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000007918 pathogenicity Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 210000001533 respiratory mucosa Anatomy 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229960002722 terbinafine Drugs 0.000 description 2
- 229960000699 terbinafine hydrochloride Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000186020 Bifidobacterium dentium Species 0.000 description 1
- 241001468229 Bifidobacterium thermophilum Species 0.000 description 1
- 241000510004 Bipes Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-IGMARMGPSA-N Carbon-12 Chemical compound [12C] OKTJSMMVPCPJKN-IGMARMGPSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 206010062343 Congenital infection Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 244000032014 Java citronella Species 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- -1 carbon fatty acid Chemical class 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000003511 ectopic pregnancy Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003694 hair properties Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 239000001289 litsea cubeba fruit oil Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940075566 naphthalene Drugs 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- 235000010298 natamycin Nutrition 0.000 description 1
- 239000004311 natamycin Substances 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
培养时间 | 活性詹氏乳酸菌组 | 灭活詹氏乳酸菌组 | P值 |
1h | 2.15±2.83 | 5.68±4.72 | <0.05 |
3h | 3.15±1.87 | 8.36±2.79 | <0.05 |
6h | 7.94±2.48 | 45.36±17.85 | <0.01 |
12h | 11.26±3.57 | 16.73±10.49 | <0.05 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711285744.2A CN107815432B (zh) | 2017-12-07 | 2017-12-07 | 一种人用灭活乳酸菌制剂及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711285744.2A CN107815432B (zh) | 2017-12-07 | 2017-12-07 | 一种人用灭活乳酸菌制剂及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107815432A true CN107815432A (zh) | 2018-03-20 |
CN107815432B CN107815432B (zh) | 2021-09-28 |
Family
ID=61605426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711285744.2A Active CN107815432B (zh) | 2017-12-07 | 2017-12-07 | 一种人用灭活乳酸菌制剂及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107815432B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110656060A (zh) * | 2019-08-09 | 2020-01-07 | 四川厌氧生物科技有限责任公司 | 多联乳杆菌组合物及其在女性***健康中的应用 |
CN110974852A (zh) * | 2019-12-09 | 2020-04-10 | 广州市锦盛生物科技有限公司 | 一种灭活乳酸菌的细胞、细胞碎片与内含物的凝胶剂及其制备方法和应用 |
CN112175867A (zh) * | 2020-09-30 | 2021-01-05 | 山东环亿生物科技有限公司 | 一种基于灭活乳酸菌的功能性无纺布 |
IT202000004663A1 (it) * | 2020-03-05 | 2021-09-05 | Marca Antonio La | Nuovo uso di probiotici |
CN114431476A (zh) * | 2022-02-28 | 2022-05-06 | 山东拜因诺生物科技有限公司 | 一种女士专用益生菌 |
CN116350561A (zh) * | 2023-05-05 | 2023-06-30 | 肽源(广州)生物科技有限公司 | 一种罗布麻发酵提取物及其制备方法和应用 |
CN117535208A (zh) * | 2024-01-04 | 2024-02-09 | 四川厌氧生物科技有限责任公司 | 一种卷曲乳杆菌及其在女性生殖道健康中的应用 |
CN117603842A (zh) * | 2023-10-17 | 2024-02-27 | 健合香港有限公司 | 一种复合菌剂及其应用 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259874A (zh) * | 1997-04-11 | 2000-07-12 | 吉尼洛吉克斯公司 | ***乳杆菌药物 |
CN1568365A (zh) * | 2001-10-12 | 2005-01-19 | 雷丁大学 | 包含戊糖乳杆菌菌株的组合物及其用途 |
CN101048168A (zh) * | 2004-10-05 | 2007-10-03 | 普罗比公司 | 用于改善的***健康的益生菌乳杆菌属菌株 |
CN101623085A (zh) * | 2008-07-08 | 2010-01-13 | 深圳市长恒生物开发有限公司 | 一种含益生菌和水苏糖的组合物 |
CN101686932A (zh) * | 2007-06-28 | 2010-03-31 | 宝洁公司 | 用于降低tsst-1产生的含钙制品 |
CN102835657A (zh) * | 2011-06-20 | 2012-12-26 | 丰华生物科技股份有限公司 | 用以抑制发炎反应及抗***炎的含乳酸菌食品组合物及医药组合物 |
CN103074270A (zh) * | 2012-11-15 | 2013-05-01 | 上海交大昂立股份有限公司 | 一种卷曲乳杆菌及其应用 |
CN104178437A (zh) * | 2013-11-08 | 2014-12-03 | 苏州欧赛微科生物医药科技有限公司 | 一种卷曲乳杆菌及其在妇科疾病中的应用 |
CN104906143A (zh) * | 2015-05-19 | 2015-09-16 | 清远海贝生物技术有限公司 | 一种灭活的乳酸菌液体制剂及其制备方法 |
WO2017014929A1 (en) * | 2015-07-23 | 2017-01-26 | The Procter & Gamble Company | Patch containing microorganism |
CN107319563A (zh) * | 2017-06-06 | 2017-11-07 | 上海真合生物技术有限公司 | 用于增强抗妇科炎症能力的益生菌组合物 |
-
2017
- 2017-12-07 CN CN201711285744.2A patent/CN107815432B/zh active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259874A (zh) * | 1997-04-11 | 2000-07-12 | 吉尼洛吉克斯公司 | ***乳杆菌药物 |
CN1568365A (zh) * | 2001-10-12 | 2005-01-19 | 雷丁大学 | 包含戊糖乳杆菌菌株的组合物及其用途 |
CN101048168A (zh) * | 2004-10-05 | 2007-10-03 | 普罗比公司 | 用于改善的***健康的益生菌乳杆菌属菌株 |
CN101686932A (zh) * | 2007-06-28 | 2010-03-31 | 宝洁公司 | 用于降低tsst-1产生的含钙制品 |
CN101623085A (zh) * | 2008-07-08 | 2010-01-13 | 深圳市长恒生物开发有限公司 | 一种含益生菌和水苏糖的组合物 |
CN102835657A (zh) * | 2011-06-20 | 2012-12-26 | 丰华生物科技股份有限公司 | 用以抑制发炎反应及抗***炎的含乳酸菌食品组合物及医药组合物 |
CN103074270A (zh) * | 2012-11-15 | 2013-05-01 | 上海交大昂立股份有限公司 | 一种卷曲乳杆菌及其应用 |
CN104178437A (zh) * | 2013-11-08 | 2014-12-03 | 苏州欧赛微科生物医药科技有限公司 | 一种卷曲乳杆菌及其在妇科疾病中的应用 |
CN104906143A (zh) * | 2015-05-19 | 2015-09-16 | 清远海贝生物技术有限公司 | 一种灭活的乳酸菌液体制剂及其制备方法 |
WO2017014929A1 (en) * | 2015-07-23 | 2017-01-26 | The Procter & Gamble Company | Patch containing microorganism |
CN107319563A (zh) * | 2017-06-06 | 2017-11-07 | 上海真合生物技术有限公司 | 用于增强抗妇科炎症能力的益生菌组合物 |
Non-Patent Citations (4)
Title |
---|
叶桂娥等: "VVC与RVVC患者治疗前后***菌群的对比研究", 《东南国防医药》 * |
梁爱玲: "低聚糖对人***产H2O2的乳杆菌体外增殖的影响", 《中国优秀硕士学位论文全文数据库_医药卫生科技辑》 * |
梅玲等: "克霉唑***片联合***用乳杆菌活菌胶囊治疗复发性外阴***假丝酵母菌病200例分析", 《中国实用医药》 * |
陈红希: "***乳杆菌活菌制剂联合克霉唑治疗复发性VVC效果观察", 《浙江临床医学》 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110656060B (zh) * | 2019-08-09 | 2020-08-07 | 四川厌氧生物科技有限责任公司 | 多联乳杆菌组合物及其在女性***健康中的应用 |
CN110656060A (zh) * | 2019-08-09 | 2020-01-07 | 四川厌氧生物科技有限责任公司 | 多联乳杆菌组合物及其在女性***健康中的应用 |
WO2021027740A1 (zh) * | 2019-08-09 | 2021-02-18 | 四川厌氧生物科技有限责任公司 | 多联乳杆菌组合物及其在女性***健康中的应用 |
CN110974852A (zh) * | 2019-12-09 | 2020-04-10 | 广州市锦盛生物科技有限公司 | 一种灭活乳酸菌的细胞、细胞碎片与内含物的凝胶剂及其制备方法和应用 |
WO2021176387A1 (en) * | 2020-03-05 | 2021-09-10 | Antonio La Marca | New use of probiotics |
IT202000004663A1 (it) * | 2020-03-05 | 2021-09-05 | Marca Antonio La | Nuovo uso di probiotici |
CN112175867A (zh) * | 2020-09-30 | 2021-01-05 | 山东环亿生物科技有限公司 | 一种基于灭活乳酸菌的功能性无纺布 |
CN114431476A (zh) * | 2022-02-28 | 2022-05-06 | 山东拜因诺生物科技有限公司 | 一种女士专用益生菌 |
CN116350561A (zh) * | 2023-05-05 | 2023-06-30 | 肽源(广州)生物科技有限公司 | 一种罗布麻发酵提取物及其制备方法和应用 |
CN116350561B (zh) * | 2023-05-05 | 2024-03-29 | 肽源(广州)生物科技有限公司 | 一种罗布麻发酵提取物及其制备方法和应用 |
CN117603842A (zh) * | 2023-10-17 | 2024-02-27 | 健合香港有限公司 | 一种复合菌剂及其应用 |
CN117535208A (zh) * | 2024-01-04 | 2024-02-09 | 四川厌氧生物科技有限责任公司 | 一种卷曲乳杆菌及其在女性生殖道健康中的应用 |
CN117535208B (zh) * | 2024-01-04 | 2024-03-29 | 四川厌氧生物科技有限责任公司 | 一种卷曲乳杆菌及其在女性生殖道健康中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN107815432B (zh) | 2021-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107815432A (zh) | 一种人用灭活乳酸菌制剂及其用途 | |
JP5112444B2 (ja) | カンジダ症及び***の予防及び/または治療のための発酵乳酸桿菌Ess−1、DSM17851及びそれの使用 | |
ES2305313T3 (es) | Bacterias que producen acido lactico para el uso como organismos probioticos en la vagina humana. | |
WO2022100633A1 (zh) | 用于预防和/或治疗生殖道菌群紊乱相关疾病的格氏乳杆菌 | |
RU2316586C2 (ru) | ПРОБИОТИЧЕСКИЕ ШТАММЫ Lactobacillus (ВАРИАНТЫ) И ИХ ПРИМЕНЕНИЕ | |
KR100336183B1 (ko) | 비루스살멸성,살균성및살정자성질좌약 | |
CN105555284B (zh) | 作为益生菌的戊糖乳杆菌菌株 | |
CN110777087B (zh) | 一种约氏乳杆菌及其应用 | |
CN110982726B (zh) | 一种卷曲乳杆菌及其应用 | |
JP2022524157A (ja) | 複合ラクトバチルス組成物およびその女性の膣の健康における用途 | |
JP2017501741A (ja) | ラクトバチルス・クリスパタスおよびその応用 | |
Nader‐Macías et al. | Probiotic lactobacilli in formulas and hygiene products for the health of the urogenital tract | |
Borges et al. | Effects of processing and storage on Pediococcus pentosaceus SB83 in vaginal formulations: lyophilized powder and tablets | |
CN100569243C (zh) | 一种治疗溃疡性结肠炎的凝结芽孢杆菌活菌制剂的制造方法和应用 | |
CN107898815A (zh) | 一种动物用灭活乳酸菌制剂及其用途 | |
CN101043856B (zh) | 用于鉴定和治疗***疾病的装置和方法 | |
CN113278548A (zh) | 卷曲乳杆菌及在生产改善人体***环境的产品中的应用 | |
CN101543514A (zh) | 预防或治疗***炎的复合乳酸菌洁阴护理液及工艺 | |
WO2004014408A1 (ja) | 膣内洗浄剤 | |
RU2413761C1 (ru) | Lactobacillus fermentum Ess-1, DSM17851, И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРОФИЛАКТИКИ КАНДИДОЗА И ИНФЕКЦИЙ МОЧЕВЫХ ПУТЕЙ | |
US20200289585A1 (en) | Composition for competitive inhibition of pathogens and restoration of microbial ecological balance | |
CN112402463A (zh) | 一种用于抑制***炎症的复合益生菌及其制品和应用 | |
KR20040101335A (ko) | 락토바실러스 균주 | |
CN110129423A (zh) | 一种利用高通量基因测序评估生殖道菌群健康的方法 | |
CN114891692B (zh) | 一种改善人体***环境的菌株及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230823 Address after: 510642 No. five, 483 mountain road, Guangzhou, Guangdong, Tianhe District Patentee after: Hu Wenfeng Address before: 510000 shop 209b-1, Yangming (International) agricultural materials commodity trading city, Guangzhou, one of 180 Tianyuan Road, Tianhe District, Guangzhou, Guangdong Patentee before: GUANGZHOU BIOFORM BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231123 Address after: 518000, 2nd Floor, Building D, No. 1168 Huanli Road, Zhenmei Community, Xinhu Street, Guangming District, Shenzhen, Guangdong Province Patentee after: Shenzhen Xianda Houshengyuan Biotechnology Co.,Ltd. Address before: 510642 No. five, 483 mountain road, Guangzhou, Guangdong, Tianhe District Patentee before: Hu Wenfeng |
|
TR01 | Transfer of patent right |